TEKLA CAPITAL MANAGEMENT LLC – CRISPR Therapeutics AG Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$3.59M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 252K | $65.35 | 55.08K | |
| Q2 2022 | share | 0.00% | 0 shares | -110K | $60.77 | 55.08K | |
| Q1 2022 | share | 0.00% | 0 shares | -717K | $62.77 | 55.08K | |
| Q4 2021 | share | Decrease | -66.07% | -107.25K shares | -13.99M | $78.85 | 55.08K |
| Q3 2021 | share | 0.00% | 0 shares | -8.11M | $111.93 | 162.33K | |
| Q2 2021 | share | Increase | +7.54% | 11.37K shares | 7.88M | $161.89 | 162.33K |
| Q1 2021 | share | Increase | +98.05% | 74.73K shares | 6.72M | $121.85 | 150.95K |
| Q4 2020 | share | 0.00% | 0 shares | 5.29M | $153.11 | 76.22K | |
| Q3 2020 | share | 0.00% | 0 shares | 773K | $83.64 | 76.22K | |
| Q2 2020 | share | 0.00% | 0 shares | 2.36M | $73.49 | 76.22K | |
| Q1 2020 | share | 0.00% | 0 shares | -1.40M | $42.41 | 76.22K | |
| Q4 2019 | share | Decrease | -24.78% | -25.11K shares | 488K | $60.91 | 76.22K |
| Q3 2019 | share | Decrease | -43.18% | -77.01K shares | -4.24M | $40.99 | 101.33K |
| Q2 2019 | share | 0.00% | 0 shares | 2.02M | $47.1 | 178.34K | |
| Q1 2019 | share | 0.00% | 0 shares | 1.27M | $35.72 | 178.34K | |
| Q4 2018 | share | 0.00% | 0 shares | -2.81M | $28.57 | 178.34K | |
| Q3 2018 | share | 0.00% | 0 shares | -2.57M | $44.35 | 178.34K | |
| Q2 2018 | share | Increase | +26.32% | 37.15K shares | 4.02M | $58.76 | 178.34K |
| Q1 2018 | share | Increase | 0.00% | 141.19K shares | 6.45M | $45.71 | 141.19K |